Rebound of COVID-19 symptoms rare after nirmatrelvir/Ritonavir treatment

Few patients experience rebound of COVID-19 symptoms after nirmatrelvir/ritonavir (NM/R) treatment, according to research published online June 14 in Clinical Infectious Diseases.